"Asia-Pacific Gene Therapy Market Summary: According to the latest report published by Data Bridge Market Research, the Asia-Pacific Gene Therapy Market Data Bridge Market Research analyzes that the Asia-Pacific gene therapy market is expected to reach USD 4,441.14 million by 2030, at a CAGR of 19.0% during the forecast period. Product accounts for the most significant type segment in...

Polaris Market Research has released its latest research report on the Cancer Gene Therapy market, offering a comprehensive view of the current market landscape and its future outlook. The report examines the major forces driving growth, including rising demand, evolving technology, expanding applications, investment flows, and competitive dynamics. It provides insight into how the market...

In an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...

The increasing demand for advanced therapy clinical research organizations, the rapid expansion of cell and gene therapy clinical trials, and growing adoption of CAR-T therapy outsourcing are transforming the global landscape of advanced therapeutics. Cell and gene therapies have emerged as revolutionary treatment approaches for cancer, rare genetic disorders, autoimmune...

The Cell & Gene Therapy Contract Research Organizations (CROs) Market is experiencing significant growth as pharmaceutical companies, biotechnology firms, and academic research institutions increasingly outsource research and clinical development activities to specialized service providers. Contract research organizations play a vital role in supporting the development of innovative cell...

Contract testing and analytical development services are creating opportunities for specialized service providers in the Cell and Gene Therapy QC & Analytics Market. Smaller biotechnology companies may rely on external laboratories for assay development, validation, characterization, and release testing. This approach can provide access to specialized equipment and technical expertise...

How does bioprocessing for CGT differ from traditional biologics? Traditional bioprocessing focuses on secreting proteins (like antibodies) from a cell. In contrast, cell and gene therapy (CGT) manufacturing often treats the cell itself as the product, or uses viral vectors for delivery. This requires a radical shift in bioprocess technology, moving from "scale-up" (larger volumes) to...

"Europe Gene Therapy Market Summary: According to the latest report published by Data Bridge Market Research, the Europe Gene Therapy Market Data Bridge Market Research analyzes that the Europe gene therapy market is expected to reach USD 7,422.28 million by 2030, at a CAGR of 17.6% during the forecast period. Product accounts for the most significant type segment in the market due...

Gene Therapy Market Accelerates Toward a New Era of Transformative Medicine Gene therapy market was valued at several billion USD in 2024 and is projected to grow at a strong double-digit CAGR through 2032, driven by rising prevalence of genetic and rare disorders, increasing approvals of gene-based treatments, and growing investments in advanced biotechnology and personalized medicine...

The gene therapy sector plays a significant role in supporting modern precision-medicine approaches by providing viral and non-viral vector-based treatments for monogenic disorders, hematological conditions, and select oncology indications. Developers are increasingly incorporating next-generation vector engineering and improved manufacturing platforms that improve treatment efficacy and safety...

" Gene Therapy Market Summary: According to the latest report published by Data Bridge Market Research, the  Gene Therapy Market The global gene therapy market size was valued at USD 10.26 billion in 2024 and is expected to reach USD 39.38 billion by 2032, at a CAGR of 18.30% during the forecast periodThe market growth is largely fueled by the growing demand for curative...

"Executive Summary Gene Therapy Market Research: Share and Size Intelligence The global gene therapy market size was valued at USD 10.26 billion in 2024 and is expected to reach USD 39.38 billion by 2032, at a CAGR of 18.30% during the forecast periodThe market growth is largely fueled by the growing demand for curative therapies and rising investments in gene therapy research....

The Gene Synthesis Market is expanding rapidly as synthetic DNA becomes increasingly important across synthetic biology, drug discovery, vaccine development, genetic engineering, and advanced therapeutic research. The market was valued at USD 2.7 billion in 2025 and is projected to grow from USD 3.1 billion in 2026 to USD 9.3 billion by 2033, registering a CAGR of 16.7% from 2026 to 2033....

"Middle East and Africa Gene Therapy Market Summary: According to the latest report published by Data Bridge Market Research, the Middle East and Africa Gene Therapy Market Data Bridge Market Research analyzes that the Middle East and Africa gene therapy market is expected to reach the value of USD 1,019.11 million by 2030, at a CAGR of 16.6% during the forecast period. Product...